AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10489005
Drug: Control Treatment
RxNorm normalized name: Control
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control Treatment (CT)
Trial: 23627650
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of 60 µg alprostadil over 3 weeks
Trial: 23627650
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion over 3 weeks
Trial: 16715252
Drug: Topical levofloxacin
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical levofloxacin 0.5%
Trial: 14739817
Drug: Basal group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal group (12 ml/h basal, 0.05-ml patient-controlled bolus dose)
Trial: 3684126
Drug: Tocolytic (ritodrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocolytic (ritodrine hydrochloride 200 micrograms/minute for 20 minutes via continuous intravenous infusion)
Trial: 28826229
Drug: Provider-administered rapid
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Provider-administered rapid blood (finger-prick) HIV test (standard of care)
Trial: 28826229
Drug: Choice between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choice between SOC or a self-administered oral rapid HIV test with provider supervision
Trial: 17370787
Drug: Intravenous tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tramadol 1.5 mg/kg
Trial: 23800312
Drug: Levofloxacin 500
RxNorm normalized name: levofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 500 mg po daily for 3 months
Trial: 16897271
Drug: Adjuvant intraportal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant intraportal infusion chemotherapy (IPIC) for patients with stage I and II disease.
Trial: 16897271
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (hepatectomy without adjuvant therapy).
Trial: 10757152
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (1 g magnesium sulfate in pump prime plus 5 mmol/L in cardioplegic solution)
Trial: 1487226
Drug: Gemfibrozil (G)
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (G)
Trial: 29672817
Drug: Intrapleural instillation
RxNorm normalized name: Talc Powder for intrapleural instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapleural instillation of 50 mL autologous blood 3 days after insertion of chest drain (Group A)
Trial: 25483677
Drug: Tecemotide (L-BLP25)
RxNorm normalized name: L
DrugBank: Tecemotide (DB12568)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tecemotide (L-BLP25)
Trial: 25483677
Drug: Single or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single or multiple low doses of cyclophosphamide
Trial: 22743596
Drug: Raltegravir (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raltegravir (400 mg bid)
Trial: 19667251
Drug: olmesartan/azelnidipine (20.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: olmesartan/azelnidipine (20.0 mg and 16.0 mg)
Trial: 19667251
Drug: olmesartan/hydrochlorothiazide (20.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: olmesartan/hydrochlorothiazide (20.0 mg and 12.5 mg)
Trial: 9537210
Drug: SK&F107647 (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SK&F107647 (dose range 0.01 to 100 ng/kg)
Trial: 7699836
Drug: SY5555 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SY5555 10 mg/kg
Trial: 334216
Drug: Nomifensine 75
RxNorm normalized name: nomifensine
DrugBank: Nomifensine (DB04821)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nomifensine 75 mg alone
Trial: 334216
Drug: Nomifensine 75
RxNorm normalized name: nomifensine
DrugBank: Nomifensine (DB04821)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nomifensine 75 mg with Clobazam 15 mg
Trial: 28063876
Drug: Breakfast (at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breakfast (at least 15% of daily energy requirement before 8:30 a.m.)
Trial: 22127708
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg belimumab plus standard therapy
Trial: 22127708
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg belimumab plus standard therapy
Trial: 22127708
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg belimumab
Trial: 22127708
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg belimumab
Trial: 17908055
Drug: Concomitant vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant vaccination with ZOSTAVAX and inactivated influenza vaccine
Trial: 17908055
Drug: Sequential vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential vaccination with ZOSTAVAX and inactivated influenza vaccine
Trial: 11600924
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (exercise program with ergonomic education, administered twice a week for four months)
Trial: 3135204
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of slow-release terbutaline
Trial: 14594020
Drug: Subcutaneous enfuvirtide
RxNorm normalized name: Enfuvirtide
DrugBank: Enfuvirtide (DB00109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous enfuvirtide added to an optimized oral background antiretroviral regimen
Trial: 14594020
Drug: Optimized oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimized oral background antiretroviral regimen
Trial: 24858376
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g TRP-rich protein hydrolysate
Trial: 20718163
Drug: Liquid simethicone
RxNorm normalized name: simethicone Oral Liquid Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid simethicone (2 ml in 60 ml of water)
Trial: 12351481
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion (10 IU of regular insulin)
Trial: 12351481
Drug: Saline alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline alone (50 ml saline)
Trial: 21178926
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (CON, LFT, HFT)
Trial: 10329827
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution injections (placebo)
Trial: 7552560
Drug: Continuous treatment
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous treatment teams
Trial: 2117202
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy (including recombinant t-PA and urokinase)
Trial: 2117202
Drug: Recombinant t-PA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant t-PA infusions
Trial: 7388323
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose heparin (1000 units/1000 ml infusate) given intravenously
Trial: 7388323
Drug: Subcutaneous low
RxNorm normalized name: Dianeal Low Calcium 1.5 Intraperitoneal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous low dose heparin (5000 units 8-hourly)
Trial: 31798841
Drug: Management-selected change
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Management-selected change agents (MSCAs)
Trial: 27284082
Drug: Active dose
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active dose of methylene blue (195 mg)
Trial: 27284082
Drug: Placebo (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (15 mg)
Trial: 19585317
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g L‐citrulline‐malate
Trial: 8638790
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine (5 micrograms/kg)
Trial: 1992957
Drug: Filicol (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filicol (9 g/d)
Trial: 1992957
Drug: Gemfibrozil (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil (1.2 g/d)
Trial: 6391497
Drug: pizotifen 1
RxNorm normalized name: Pizotifen 1.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pizotifen 1 mg
Trial: 30851515
Drug: MTX +
RxNorm normalized name: MTX
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: MTX + SIN (Methotrexate + Sinomenine) at a dose of 120 mg twice daily
Trial: 30851515
Drug: MTX +
RxNorm normalized name: MTX
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: MTX + LEF (Methotrexate + Leflunomide) at a dose of 20 mg once daily
Trial: 26503762
Drug: Oxytocin nasal
RxNorm normalized name: oxytocin Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin nasal spray (12 IU morning and night, 24 IU per day for 5 weeks)
Trial: 20123246
Drug: AFT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AFT plus medical therapy
Trial: 17599852
Drug: Sliding scale
RxNorm normalized name: wing scale pollen extract
DrugBank: Atriplex canescens pollen (DB10767)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sliding scale regular insulin (SSRI)
Trial: 17599852
Drug: Intravenous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous insulin infusion in ICU
Trial: 2186220
Drug: Phthivazide 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phthivazide 0.5 g three times a day for 15-20 days
Trial: 30573719
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg dexketoprofen trometamol + 8 mg thiocolchicoside
Trial: 30573719
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg dexketoprofen trometamol
Trial: 30573719
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg dexketoprofen trometamol + 4 mg thiocolchicoside
Trial: 25923482
Drug: Cysteine-rich whey
RxNorm normalized name: Whey
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cysteine-rich whey protein isolate (Immunocal®) 20 g/day
Trial: 25923482
Drug: Casein 20
RxNorm normalized name: caseins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casein 20 g/day
Trial: 8127888
Drug: Melatonin (0.1‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (0.1‐10 mg, orally)
Trial: 324400
Drug: Minocycline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline (100 mg every 12 h for 5 days)
Trial: 25947184
Drug: Laughter therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laughter therapy (5 times a week for 2 weeks)
Trial: 12616665
Drug: Zidovudine (ZDV)
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine (ZDV) alone or in combination with didanosine
Trial: 9089002
Drug: Mini 30
RxNorm normalized name: UltiCare Mini 30G 3/16 inch Safety Pen Needle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mini 30 (0.03 mg levonorgestrel)
Trial: 1345050
Drug: Active antihypertensive
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active antihypertensive therapy
Trial: 3009962
Drug: nabilone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nabilone (2 X 2 mg/day)
Trial: 3009962
Drug: alizapride (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alizapride (3 X 150 mg/day)
Trial: 23137509
Drug: Intramyocardial bone
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramyocardial bone marrow cell (BMC) injection (100 × 10^6 BMC)
Trial: 23137509
Drug: Intramyocardial bone
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramyocardial bone marrow cell (BMC) injection
Trial: 12219064
Drug: PEG 3350
RxNorm normalized name: PEG 3350
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG 3350 at 1 g/kg per day
Trial: 1026547
Drug: 0-1% halcinonide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0-1% halcinonide cream (with neomycin and nystatin)
Trial: 20223497
Drug: Intravenous taurolidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous taurolidine in crystalloid cardioplegia
Trial: 20223497
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion of normal saline in crystalloid cardioplegia
Trial: 20223497
Drug: Intravenous taurolidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous taurolidine in blood cardioplegia
Trial: 20223497
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion of normal saline in blood cardioplegia
Trial: 1748135
Drug: Felodipine 10
RxNorm normalized name: felodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 10 mg ER o.d.
Trial: 1748135
Drug: Hydrochlorothiazide 25
RxNorm normalized name: hydrochlorothiazide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 25 mg o.d.
Trial: 15906759
Drug: Physiological solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological solution (control)
Trial: 15906759
Drug: Octreotide (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide (administered to 7 patients post-study)
Trial: 12388617
Drug: Dopaminergic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopaminergic therapy (dopamine-replete state)
Trial: 12388617
Drug: Hypodopaminergic state
RxNorm normalized name: CLOZAPINE (GOLDEN STATE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypodopaminergic state (i.e., > or =12 hr after last dose of dopaminergic treatment)
Trial: 8775804
Drug: Saquinavir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir monotherapy
Trial: 8775804
Drug: Saquinavir combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir combination therapy with zidovudine
Trial: 8775804
Drug: Saquinavir combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir combination therapy with zidovudine and zalcitabine
Trial: 8775804
Drug: Saquinavir at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir at higher doses (2-4 times higher)
Trial: 27868327
Drug: Doctor-patient communication
RxNorm normalized name: Doctor's Choice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doctor-patient communication with a focus on discussing medication themes and lifestyle treatment.
Trial: 17110396
Drug: Both CC
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both CC and rFSH
Trial: 9484914
Drug: Chemotherapy given
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy given prior to or simultaneously with definite radiotherapy
Trial: 15018017
Drug: Low-dose isotretinoin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose isotretinoin
Trial: 12828803
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy (CT) for depression
Trial: 11237928
Drug: Chlorogenic acid
RxNorm normalized name: chlorogenic acid
DrugBank: Chlorogenic Acid (DB12029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorogenic acid (2 g daily)
Trial: 11237928
Drug: Black tea
RxNorm normalized name: black tea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black tea (4 g daily)
Trial: 11237928
Drug: Quercetin‐3‐rutinoside (440
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin‐3‐rutinoside (440 mg daily)
Trial: 11407649
Drug: Sumatriptan (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan (6 mg sc)
Trial: 8280556
Drug: Piroximone (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroximone (loading dose of 0.5 mg kg‐1 followed by an infusion of 5 micrograms kg‐1 min‐1)
Trial: 24917119
Drug: Grintuss® pediatric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grintuss® pediatric syrup
Trial: 22401329
Drug: Monthly group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly group medical visits (GMVs)
Trial: 16317218
Drug: Granisetron 1
RxNorm normalized name: granisetron 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 1 mg IV plus dexamethasone 20 mg (group A)
Trial: 16317218
Drug: Granisetron 3
RxNorm normalized name: granisetron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 3 mg IV plus dexamethasone 20 mg (group B)
Trial: 8864768
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of PHT and PB
Trial: 8864768
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CBZ and PB
Trial: 8864768
Drug: Drug-free (DF)
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-free (DF)
Trial: 6383763
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg dipyridamole intravenously
Trial: 24475198
Drug: Active case
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active case detection method (children monitored actively, visited twice weekly, tympanic temperature measured, malaria rapid diagnostic test performed if fever present)
Trial: 11697755
Drug: Intranasal lorazepam
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal lorazepam (2 mg)
Trial: 21837394
Drug: Buccal lorazepam
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buccal lorazepam (2 mg)
Trial: 15650833
Drug: Home-based daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based daily exercise therapy (20-min exercise program once per day for 8 weeks)
Trial: 15650833
Drug: Home-based daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based daily exercise therapy
Trial: 12815801
Drug: Oral antihistamines
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antihistamines and topical steroids
Trial: 7728916
Drug: AVS plus
RxNorm normalized name: Sentry AV Ornacyn-Plus 29 MG Powder for Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVS plus intravenous immunoglobulin (IVIG)
Trial: 23467275
Drug: G‐CSF (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF (5 μg/kg per day, six doses) plus standard therapy
Trial: 3318896
Drug: Nalbuphine 10
RxNorm normalized name: nalbuphine 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine 10 mg ml‐1 (group N)
Trial: 3318896
Drug: Buprenorphine 0.15
RxNorm normalized name: buprenorphine 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 0.15 mg ml‐1 (group B)
Trial: 29289540
Drug: Linagliptin 5
RxNorm normalized name: linagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linagliptin 5 mg/d
Trial: 23805859
Drug: Naltrexone 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 25 mg/day
Trial: 19027483
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 mg/m2 intravenously every 3 weeks)
Trial: 17329466
Drug: Risperidone (1.5-6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (1.5-6.0 mg/day)
Trial: 20205984
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg isoflavones
Trial: 11216491
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg and 40 mg isoflavones
Trial: 27977721
Drug: Itraconazole capsules
RxNorm normalized name: Itraconazole Capsules
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole capsules (100 mg QD) for 14 days
Trial: 11476474
Drug: Allergen-specific immunotherapy
RxNorm normalized name: Pacific halibut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allergen-specific immunotherapy (SIT)
Trial: 26901657
Drug: Computer-assisted cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-assisted cognitive behavioral therapy
Trial: 17178181
Drug: Gabapentin 400
RxNorm normalized name: gabapentin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 400 mg q.i.d. on days 1 and 2
Trial: 19880464
Drug: Enriched Supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enriched Supportive Therapy (EST)
Trial: 3138681
Drug: misoprostol 400
RxNorm normalized name: Misoprostol 400 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: misoprostol 400 micrograms twice daily for 28 days
Trial: 3138681
Drug: propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propranolol 80 mg twice daily for four weeks with misoprostol 400 micrograms twice daily during the second and third weeks